Evidence map›Paper›PMID 40196145›Full record

ArticleArXiv2025

Combining multiplexed functional data to improve variant classification.

Jeffrey D Calhoun, Moez Dawood, Charlie F Rowlands, Shawn Fayer, Elizabeth J Radford, Abbye E McEwen, Clare Turnbull, Amanda B Spurdle, Lea M Starita, Sujatha Jagannathan

Abstract readPreprint
In one paragraph

Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jeffrey D CalhounKen and Ruth Davee Department of Neurology, Northwestern Feinberg School of Medicine, Chicago, Illinois.
Moez DawoodHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
Charlie F RowlandsDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Shawn FayerBrotman Baty Institute for Precision Medicine, Seattle, WA, USA.
Elizabeth J RadfordWellcome Sanger Institute, Hinxton, CB10 1SA, UK.
Abbye E McEwenBrotman Baty Institute for Precision Medicine, Seattle, WA, USA.
Clare TurnbullDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Amanda B SpurdlePopulation Health Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.
Lea M StaritaDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Sujatha JagannathanDepartment of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Funding

The Baylor-Hopkins Clinical Genomics Center for All of UsOT2OD002751 · OD · BAYLOR COLLEGE OF MEDICINE · PI BOERWINKLE, ERIC A., DOHENY, KIMBERLY F · 2018 to 2023
$152.8M
Technology to understand genetic variant effects in contextRM1HG010461 · NHGRI · UNIVERSITY OF WASHINGTON · PI Douglas M Fowler, Bruce Colston Trapnell · 2019 to 2026
$18.9M
Frequency of variants of unknown significance by ancestry groups in the All of Us Research Program cohortU01HG011758 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI RICHARD A GIBBS, JAMES R. LUPSKI · 2021 to 2026
$13.8M
The Center for Actionable Variant Analysis; measuring variant function at scaleUM1HG011969 · NHGRI · UNIVERSITY OF WASHINGTON · PI Douglas M Fowler, Lea Starita · 2021 to 2026
$9.9M
Understanding the variability in nonsense-mediated RNA decayR35GM133433 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI Sujatha Jagannathan · 2019 to 2026
$3.1M
Advancing the implementation of variant-level functional data into clinical databases and clinical practiceR01HG013025 · NHGRI · UNIVERSITY OF WASHINGTON · PI Lea Starita, Andrew Ben Stergachis · 2023 to 2026
$3.1M
NHGRI NIH HHS R01 HG013025NHGRI NIH HHS RM1 HG010461NHGRI NIH HHS U01 HG011758NHGRI NIH HHS UM1 HG011969NIGMS NIH HHS R35 GM133433NIH HHS OT2 OD002751
6 · The paper itself

Abstract

With the surge in the number of variants of uncertain significance (VUS) reported in ClinVar in recent years, there is an imperative to resolve VUS at scale. Multiplexed assays of variant effect (MAVEs), which allow the functional consequence of 100s to 1000s of genetic variants to be measured in a single experiment, are emerging as a source of evidence which can be used for clinical gene variant classification. Increasingly, there are multiple published MAVEs for the same gene, sometimes measuring different aspects of variant impact. Where multiple functional consequences may need to be considered to get a more complete understanding of variant effects for a given gene, combining data from multiple MAVEs may lead to the assignment of increased evidence strength which could impact variant classifications. Here, we provide guidance for combining such multiplexed functional data, incorporating a stepwise process from data curation and collection to model generation and validation. We illustrate the potential of this approach by showing the integration of multiplexed functional data from four MAVEs for the gene

Identifiers

PMID40196145
PMCPMC11975307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.